Good Start

Good Start Genetics is a molecular diagnostics company focused on providing advanced genetic testing for reproductive health. The company utilizes next-generation sequencing and other proprietary technologies to offer comprehensive carrier screening for prospective parents. Their primary product, GeneVu, screens for a wide range of genetic disorders to help families make informed reproductive decisions. The company also developed VeriYou, an at-home genetic screening test for common inherited conditions. Following its acquisition by Invitae in 2017, its technologies and tests were integrated into Invitae's broader genetic testing portfolio. The company was recognized for its clinical rigor and its role in making NGS-based screening a standard in fertility clinics.